Test Strips Market Demonstrates Long-Term Growth Potential At 4.5% CAGR

The test strips market is poised for consistent expansion over the coming years, driven by technological progress and increasing healthcare demands. As innovations emerge and adoption grows across various healthcare settings, this market is set to experience substantial developments up to 2030. Let's explore the market's size projections, key players, trends, segmentation, and notable recent activities shaping its future.

Forecasted Growth Trajectory for the Test Strips Market Through 2030
The test strips market is anticipated to grow steadily, reaching a value of $85.21 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 4.5% during the forecast period. Several factors contribute to this growth, including advances in biosensor technologies, increased use of digital health platforms, broader availability of hospital and homecare services, a rise in chronic disease cases, and the integration of AI-driven diagnostic tools. Key trends expected to influence the market include a growing preference for home-based testing solutions, demand for multi-parameter test strips, incorporation with mobile health apps, expansion of point-of-care diagnostics, and an emphasis on rapid, accurate detection methods.

Download a free sample of the Test Strips market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24721&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Prominent Players Leading the Test Strips Market Landscape
The test strips sector features several leading companies that dominate the competitive landscape. These include Johnson & Johnson, F Hoffmann La Roche Ltd, Abbott Laboratories, Abbott Diabetes Care, Siemens Healthcare GmbH, Becton dic*kinson and Company, bioMerieux SA, Bio Rad Laboratories Inc, TaiDoc Technology Corporation, Macherey Nagel GmbH and Co KG, OneTouch, EKF Diagnostics Holdings plc, Bionime Corporation, ACON Laboratories Inc, i SENS Inc, BTNX Inc, ARKRAY Inc, Ascensia Diabetes Care, LifeScan Inc, Nova Biomedical, Trividia Health, and Nipro Diagnostics.

A notable industry development took place in February 2025, when Safe Supply Streaming Co. Ltd., a Canadian medical company, acquired US-based Safety Strips Tech Corp. for an undisclosed sum. This move aims to broaden Safe Supply Streaming's portfolio within diagnostic test strips, enhance its technological expertise, and strengthen its global market position.

View the full Test Strips market report:
https://www.thebusinessresearchcompany.com/report/test-strips-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends Highlighting Innovations and Opportunities in the Test Strips Market
Innovation is a key focus among market leaders, with an emphasis on developing advanced products like drug detection test strips that improve detection accuracy and user convenience. Drug detection test strips are compact, portable devices designed to swiftly identify specific drugs or their metabolites in biological samples such as urine or saliva.

For example, in September 2024, Greenlane Holdings Inc., a US-based distributor specializing in cannabis* accessories, launched detection strips for substances including fentaNYL, Xylazine, and common drink spiking agents like benzodiazepines and ketamine. These strips provide high sensitivity and reliable results within two minutes, featuring easy-to-use dip-and-read or drop-and-wait formats with clear visual indicators. Their portability and disposability make them ideal for use in bars, nightclubs, festivals, and personal safety kits.

Comprehensive Segmentation of the Test Strips Market
The test strips market is categorized by product type, distribution channel, application, and end user.

By product type, the market is divided into blood test strips, urine test strips, and other product types. Distribution channels include online retail, offline retail, direct sales, hospital supply chains, and specialized distributors. Applications cover diabetes, infectious disease, cardiac marker testing, pregnancy and fertility testing, and other medical uses. End users comprise hospitals and clinics, homecare settings, diagnostic laboratories, and other consumers.

Further subsegments provide detailed categorization:
- Blood test strips consist of glucose, cholesterol, hemoglobin, ket*one, and coagulation test strips.
- Urine test strips include pH, protein, glucose, ket*one, leukocyte and nitrite, specific gravity, and microalbumin test strips.
- Other product types cover saliva strips, sweat strips, multi-parameter strips, drug of abuse strips, and fertility or pregnancy strips.

This nuanced segmentation helps stakeholders understand the market dynamics and identify opportunities across various applications and distribution methods.

New additions to our 2026 reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.